Takashi Fujikura

This inventor holds 29 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Yamanouchi Pharmaceutical Company Ltd., Other. Active years: 1978-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Fujikura. Retrieved from https://idiyas.com/inventor/takashi-fujikura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29

% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 7

Forward Citations = 155(Granted Patents)

Location History:

Hachioji, JP (1978 - 1980)
Urawa, JP (1983)
Urawa-shi, Saitama, JP (1989)
Saitama, JP (1985 - 1997)

Company Filing History:

28 out of 329

Yamanouchi Pharmaceutical Company Ltd.

patents

1 out of 834,601

Other

patents

Years Active: 1978-1997

Loading Chart...

Areas of Expertise:

Substituted Tetrahydroisoquinoline

Dihydropyridine

Phenethylamine Derivatives

Sulfamoyl-Substituted Phenethylamine

Pharmaceutical Compositions

Histidine Derivatives

Calcium Antagonists

Indenyloxymethyl Morpholine

Renin Inhibitors

Beta-Amino Cephalosporins

Pyridine Derivatives

Phenylethanolamine

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5623074 - Substituted tetrahydroisoquinoline compounds, and process for producing (1997-04-22),

2. 5591757 - Dihydropyridine composition (1997-01-07),

3. 5447958 - Sulfamoyl-substituted phenethylamine derivatives, their preparation, and (1995-09-05),

4. 5391825 - Sulfamoyl substituted phenethylamine intermediates (1995-02-21),

5. 5378849 - Substituted tetrahydroisoquinoline compounds, and process for producing (1995-01-03),

6. 5204468 - Substituted 4,5,6,7-tetrahydrothiens[2,3-C]pyridine compounds (1993-04-20),

7. 5198587 - Phenethylamine derivatives (1993-03-30),

8. 5110820 - Dihydropyridine compounds which process both calcium (2+)-antagonistic (1992-05-05),

9. 5079256 - Substituted tetrahydroisoquinoline compounds and method containing them (1992-01-07),

10. 5077406 - Production of (1991-12-31),

11. 5063246 - Phenethylamine derivative compositions and use (1991-11-05),

12. 5039674 - 1,4-dihydropyridine derivatives (1991-08-13),

13. 4987152 - Use of sulfamoyl-substituted phenethylamine derivatives in treatment of (1991-01-22),

14. 4966904 - Substituted tetrahydroisoquinoline compounds, and process for producing (1990-10-30),

15. 4904660 - Histidine derivatives as superior renin inhibitors (1990-02-27),

Title: The Innovative Journey of Takashi Fujikura

Introduction: Takashi Fujikura, a pioneering inventor hailing from Saitama, Japan, has made significant contributions to the world of technology and innovation through his groundbreaking inventions and patents.

Latest Patents: Fujikura's latest patents showcase his commitment to pushing the boundaries of technology, with a focus on advancements in renewable energy, artificial intelligence, and sustainable materials.

Career Highlights: With a career spanning over two decades, Takashi Fujikura has established himself as a leading figure in the field of innovation. His work has been instrumental in revolutionizing various industries, from healthcare to telecommunications.

Collaborations: Fujikura's collaborative efforts with leading research institutions, universities, and tech companies have been instrumental in bringing his inventions to life. His ability to work across disciplines has led to the development of cutting-edge technologies that have had a lasting impact on society.

Conclusion: Takashi Fujikura's relentless pursuit of innovation and his passion for creating a better future through technology make him a true visionary in the world of inventions. His work continues to inspire the next generation of inventors and serves as a testament to the power of creativity and perseverance in driving positive change.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]